Crossmark

A novel frequent BRCA1 recurrent variant c.5117G > A (p.Gly1206Glu) identified after 20 years of BRCA1/2 research in the Baltic region: cohort study and literature review

Crossref DOI link: https://doi.org/10.1186/s13053-021-00168-z

Published Online: 2021-01-19

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Loza, P. https://orcid.org/0000-0002-8358-7251
Irmejs, A.

Daneberga, Z.

Miklasevics, E.

Berga-Svitina, E.

Subatniece, S.

Maksimenko, J.

Trofimovics, G.

Tauvena, E.

Ukleikins, S.

Gardovskis, J.
Funding

Funding for this research was provided by:

Riga Stradins University
License Information

Text and Data Mining valid from 2021-01-19

Version of Record valid from 2021-01-19
More Information

Article History

Received: 27 October 2020

Accepted: 5 January 2021

First Online: 19 January 2021

Ethics approval and consent to participate

: This study was approved by a Central Medical Ethics Committee of Latvia (03.6.2019. Nr.3/19–06-03) and Genome Research Council of Latvia (04.07.2019. Nr.A-12/19–07-04).

: All individuals provided written informed consent, including for publication.

: All authors declare that they have no competing interests.

Document is current

Any future updates will be listed below